Search results

Order by most recent / most popular / relevance

Results: 1-10 of 26

Celgene Corporation v Canada (AG) - Supreme Court of Canada grants leave to appeal

Gowling Lafleur Henderson LLP
-
Canada
-
May 21 2010

The Supreme Court of Canada has granted Celgene Corporation's application for leave to appeal the decision of a majority of the Federal Court of Appeal regarding the jurisdiction of the Patented Medicine Prices Review Board

An overview of Ontario’s proposed drug pricing regulatory reforms

McMillan LLP
-
Canada
-
April 26 2010

Recently announced changes to Ontario's drug pricing laws will potentially have a significant impact on the bottom line of many stakeholders in the Ontario generic drug industry

First PMPRB decision dismissing allegations of excessive pricing

Gowling Lafleur Henderson LLP
-
Canada
-
April 20 2010

The Patented Medicine Prices Review Board ("PMPRB") recently released its decision in the matter of Hoechst Marion Roussel Canada Inc. and the medicine NIOCODERM, a nicotine patch which assists those who are attempting to quit smoking; it is to be publicly posted on the PMPRB website today

Patent settlement agreements and the Competition Act “something more” required for conspiracy

McCarthy Tétrault LLP
-
Canada
-
February 11 2010

The Federal Court of Appeal recently confirmed that patent settlement agreements may be subject to the provisions of the Competition Act; however, "something more" than a mere assertion of patent rights is required to amount to conspiracy under the Act

PMPRB guidelines and reporting requirements in effect for 2010

Gowling Lafleur Henderson LLP
-
Canada
-
January 22 2010

The Patented Medicine Prices Review Board (PMPRB) released new Guidelines in 2009, including the new pricing tests the Board will apply for patented medicines

Canada (Attorney General) v. Celgene Corporation, appeal of a PMPRB decision

Gowling Lafleur Henderson LLP
-
Canada
-
January 20 2010

The Court of Appeal overturned the decision of the Trial Judge and restored the decision of the PMPRB providing jurisdiction to the PMPRB over medicines imported under the Special Access Program

Court overturns PMPRB's decisions in respect of the medicine copaxone

Gowling Lafleur Henderson LLP
-
Canada
-
November 18 2009

On November 12, 2009, Justice Hughes of the Federal Court allowed two judicial review applications of Teva Neuroscience G.P.-S.E.N.C. in respect of two decisions made by the Patented Medicine Prices Review Board

Laboratoires Servier et al. v. Apotex: the patent antitrust turf war continues

McMillan LLP
-
Canada
-
April 28 2009

The recently decided case of Les Laboratoires Servier et al. v. Apotex et al. is a further example of the ongoing high-stakes litigation between generic and name brand pharmaceutical companies, which has involved both patent and, increasingly, also competition law principles

Competition Bureau releases follow-up report on generic drug competition

Osler, Hoskin & Harcourt LLP
-
Canada
-
December 2 2008

On November 25, 2008, the Competition Bureau released its second report, Benefiting from Generic Drug Competition in Canada: The Way Forward, on the competitive framework for generic drugs in Canada